Skip to main navigation
LinkedIn
Twitter
Investors
Careers
About
Overview
Senior Leadership
Board of Directors
Pipeline
ONS-5010 / LYTENAVA™ OVERVIEW
ONS-5010 CLINICAL PROGRESS
UNMET PATIENT NEEDS
REPACKAGED IV BEVACIZUMAB
NEW OPHTHALMIC ANTI-VEGF
POTENTIAL FIRST-LINE THERAPY
News
Contact
Search for:
Event Details
Home
/
Investors
/
Events
/
Outlook Therapeutics at H.C. Wainwright BioConnect Conference
Outlook Therapeutics at H.C. Wainwright BioConnect Conference
Jan 10, 2022 at 7:00 AM EST
Print Page
Email Page
RSS Feeds
Email Alerts
Contact IR
